Tudor Investment Corp’s Halozyme HALO Stock Holding History

Tudor Investment Corp’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-61,683	Closed	-$4.15M	–	3699
2025 Q3	$4.52M	Buy	61,683 +22,543	+58%	+$1.5M	0.01%	1255
2025 Q2	$2.04M	Buy	+39,140	New	+$2.23M	﹤0.01%	1662
2021 Q1	–	Sell	-20,785	Closed	-$888K	–	1683
2020 Q4	$888K	Sell	20,785 -68,415	-77%	-$2.46M	0.03%	731
2020 Q3	$2.34M	Buy	+89,200	New	+$2.48M	0.1%	237
2018 Q2	–	Sell	-17,373	Closed	-$340K	–	1119
2018 Q1	$340K	Sell	17,373 -13,264	-43%	-$257K	0.01%	688
2017 Q4	$621K	Buy	30,637 +11,872	+63%	+$218K	0.02%	513
2017 Q3	$326K	Sell	18,765 -27,338	-59%	-$370K	0.01%	796
2017 Q2	$591K	Buy	+46,103	New	+$616K	0.02%	513
2015 Q4	–	Sell	-26,655	Closed	-$358K	–	1718
2015 Q3	$358K	Buy	+26,655	New	+$535K	0.01%	981

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tudor Investment Corp's HALO Position: Q4 2025 in Review

Tudor Investment Corp sold out of Halozyme (HALO) in Q4 2025, closing a stake of 61,683 shares — an estimated $4.15M sold.

Tudor Investment Corp first reported a position in HALO in Q3 2015 and held it in 9 quarters. The position peaked at $4.52M in Q3 2025. 617 funds tracked by Wall St. Rank hold HALO as of Q4 2025.

Tudor Investment Corp reported no remaining Halozyme position as of Q4 2025 after selling out during the quarter.
Tudor Investment Corp sold 61,683 Halozyme shares in Q4 2025, an estimated $4.15M.
Tudor Investment Corp first reported a position in Halozyme in Q3 2015 and held it in 9 quarters.
Tudor Investment Corp's Halozyme position peaked at $4.52M in Q3 2025.
617 funds tracked by Wall St. Rank held Halozyme as of Q4 2025.

Based on Tudor Investment Corp's 13F filing for Q4 2025, filed 17 Feb 2026.